Missing Protein Provides Clue To Ovarian Cancer Drug Success, UK

Scientists have discovered a protein which could improve the success rate of the tumour shrinking drug paclitaxel, in the treatment of ovarian cancer, a study reveals in Cancer Cell. The researchers, funded by Cancer Research UK and the Medical Research Council, found that the loss of a protein called TGFBI caused paclitaxel to fail. [click link for full article]

More: continued here

Filed under: Cervical Cancer on December 15th, 2007